Sintx Technologies, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory
Sintx Technologies, Inc. (SINT) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory of $8.00 thousand as of 2025-02-19, per its 10-K filed 2026-03-20.
Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Asset › Business Combination, Recognized Asset Acquired, Asset, Current
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory · last filed 2026-03-20
- 2025-02-19: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory $8.00K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory |
|---|---|
| 2025-02-19 | $8.00K 10-K · filed 2026-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |